Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics  is organized by CME Institute of Physicians Postgraduate Press, Inc. (PPP)

Activity opens: 08/03/2021
Activity expires: 08/31/2023

Description:
What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?

Learning Objectives:
Use current evidence to weigh risks of atypical antipsychotic prescription in pregnant women

Additional details will be posted as soon as information is available.